GRAL logo

GRAIL (GRAL) Company Overview

Profile

Full Name:

GRAIL, Inc.

Sector:

Healthcare

Country:

United States

IPO:

June 12, 2024

Indexes:

Not included

Description:

GRAIL LLC is a biotechnology company focused on early cancer detection. They develop innovative blood tests that can identify multiple types of cancer at an early stage, improving treatment options and patient outcomes. Their mission is to save lives through advanced diagnostic technology.

Events Calendar

Earnings

Next earnings date:

Feb 28, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Nov 27, 24 Morgan Stanley
Equal-Weight
Oct 17, 24 Guggenheim
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Watch These Grail Price Levels After Med Tech Company's Stock Soared 64% Last Week
Watch These Grail Price Levels After Med Tech Company's Stock Soared 64% Last Week
Watch These Grail Price Levels After Med Tech Company's Stock Soared 64% Last Week
GRAL
investopedia.comJanuary 27, 2025

Grail (GRAL) shares could remain in focus after surging to a new record high on Friday to cap off a huge week of gains amid optimism about the medical technology company's early-detection cancer screening blood tests.

Patient Reported Outcomes for GRAIL's Galleri® Multi-Cancer Early Detection Blood Test Published in Lancet Oncology
Patient Reported Outcomes for GRAIL's Galleri® Multi-Cancer Early Detection Blood Test Published in Lancet Oncology
Patient Reported Outcomes for GRAIL's Galleri® Multi-Cancer Early Detection Blood Test Published in Lancet Oncology
GRAL
prnewswire.comJanuary 13, 2025

Analysis of Patient Reported Outcomes From PATHFINDER Indicate Minimal Patient Distress Associated with Multi-Cancer Early Detection Testing MENLO PARK, Calif. , Jan. 13, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL) a healthcare company whose mission is to detect cancer early when it can be cured, today announced that patient-reported outcomes (PRO) assessing patient perspectives from the PATHFINDER study were published in Lancet Oncology.

GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference
GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference
GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference
GRAL
prnewswire.comDecember 18, 2024

MENLO PARK, Calif. , Dec. 18, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the 43rd Annual J.P.

GRAIL: Biotech Stock Targeting $100B Cancer Market
GRAIL: Biotech Stock Targeting $100B Cancer Market
GRAIL: Biotech Stock Targeting $100B Cancer Market
GRAL
marketbeat.comDecember 14, 2024

GRAIL NASDAQ: GRAL is a small-cap biotechnology company that has gone on a very strong run over the last month and a half. Shares of the healthcare stock are up 58% since Oct. 24, as of the Dec. 11 close.

World's biggest hedge fund flags the ‘holy grail' that may shield investors if U.S. stock rally crumbles
World's biggest hedge fund flags the ‘holy grail' that may shield investors if U.S. stock rally crumbles
World's biggest hedge fund flags the ‘holy grail' that may shield investors if U.S. stock rally crumbles
GRAL
marketwatch.comDecember 5, 2024

Karen Karniol-Tambour, co-chief investment officer at Bridgewater Associates, says valuations are much higher for U.S. stocks than they were when the bull run began.

GRAIL to Participate in Upcoming Investor Conferences
GRAIL to Participate in Upcoming Investor Conferences
GRAIL to Participate in Upcoming Investor Conferences
GRAL
prnewswire.comNovember 19, 2024

MENLO PARK, Calif. , Nov. 19, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will participate in the following investor conferences.

GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study
GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study
GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study
GRAL
prnewswire.comNovember 18, 2024

MENLO PARK, Calif. , Nov. 18, 2024  /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that the first patient has been tested for eligibility with the investigational GRAIL Non-Small Cell Lung Cancer (NSCLC) ctDNA Assay in the global TROPION-Lung12 Phase 3 study evaluating adjuvant treatment regimens in patients with Stage I adenocarcinoma NSCLC.

GRAIL Inc. (GRAL) Q3 2024 Earnings Call Transcript
GRAIL Inc. (GRAL) Q3 2024 Earnings Call Transcript
GRAIL Inc. (GRAL) Q3 2024 Earnings Call Transcript
GRAL
seekingalpha.comNovember 15, 2024

GRAIL Inc. (NASDAQ:GRAL ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Robert Ragusa - CEO & Director Aaron Freidin - Chief Financial Officer Joshua Ofman - President Harpal Kumar - President, International Business and BioPharma Conference Call Participants Operator Good day, ladies and gentlemen, and welcome to the GRAIL Third Quarter 2024 Earnings Call. [Operator Instructions] Please be advised that this conference call is being recorded.

GRAIL Reports Third Quarter 2024 Financial Results
GRAIL Reports Third Quarter 2024 Financial Results
GRAIL Reports Third Quarter 2024 Financial Results
GRAL
prnewswire.comNovember 12, 2024

Galleri Revenue Grew 52% Year-Over-Year to $25.4 Million Commercial Galleri Sales Surpassed 250,000 Tests Since Launch Cash Balance of $853.6 Million Provides Runway Into 2028 MENLO PARK, Calif. , Nov. 12, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial results for the third quarter 2024.

GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
GRAL
prnewswire.comNovember 4, 2024

MENLO PARK, Calif. , Nov. 4, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York on Thursday, Nov. 21 at 11:00 a.m.

  • 1(current)
  • 2
  • 3
  • 1(current)
  • 2
  • 3

FAQ

  • What is the ticker symbol for GRAIL?
  • Does GRAIL pay dividends?
  • What sector is GRAIL in?
  • What industry is GRAIL in?
  • What country is GRAIL based in?
  • When did GRAIL go public?
  • Is GRAIL in the S&P 500?
  • Is GRAIL in the NASDAQ 100?
  • Is GRAIL in the Dow Jones?
  • When was GRAIL's last earnings report?
  • When does GRAIL report earnings?
  • Should I buy GRAIL stock now?

What is the ticker symbol for GRAIL?

The ticker symbol for GRAIL is NASDAQ:GRAL

Does GRAIL pay dividends?

No, GRAIL does not pay dividends

What sector is GRAIL in?

GRAIL is in the Healthcare sector

What industry is GRAIL in?

GRAIL is in the Diagnostics & Research industry

What country is GRAIL based in?

GRAIL is headquartered in United States

When did GRAIL go public?

GRAIL's initial public offering (IPO) was on June 12, 2024

Is GRAIL in the S&P 500?

No, GRAIL is not included in the S&P 500 index

Is GRAIL in the NASDAQ 100?

No, GRAIL is not included in the NASDAQ 100 index

Is GRAIL in the Dow Jones?

No, GRAIL is not included in the Dow Jones index

When was GRAIL's last earnings report?

GRAIL's most recent earnings report was on Nov 12, 2024

When does GRAIL report earnings?

The next expected earnings date for GRAIL is Feb 28, 2025

Should I buy GRAIL stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions